As Europe re-evaluates its pharmaceutical policy framework the challenge for the next decade(s) is not
if medical innovation will happen, but
where it will happen.
Five EFPIA Board members tell us why it matters to patients, to health systems, to our research ecosystem and to our economy. Read more
here....